These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 32017138)

  • 21. Prognostic significance of brain-derived neurotrophic factor levels in patients with heart failure and reduced left ventricular ejection fraction.
    Barman HA; Şahin I; Atıcı A; Durmaz E; Yurtseven E; Ikitimur B; Okuyan E; Keleş I
    Anatol J Cardiol; 2019 Nov; 22(6):309-316. PubMed ID: 31789613
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Waon therapy improves quality of life as well as cardiac function and exercise capacity in patients with chronic heart failure.
    Sobajima M; Nozawa T; Fukui Y; Ihori H; Ohori T; Fujii N; Inoue H
    Int Heart J; 2015; 56(2):203-8. PubMed ID: 25740582
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acute and short-term efficacy of sauna treatment on cardiovascular function: A meta-analysis.
    Li Z; Jiang W; Chen Y; Wang G; Yan F; Zeng T; Fan H
    Eur J Cardiovasc Nurs; 2020 Feb; 20(2):96-105. PubMed ID: 32814462
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of BNP and NT-proBNP in Patients With Heart Failure and Reduced Ejection Fraction.
    Rørth R; Jhund PS; Yilmaz MB; Kristensen SL; Welsh P; Desai AS; Køber L; Prescott MF; Rouleau JL; Solomon SD; Swedberg K; Zile MR; Packer M; McMurray JJV
    Circ Heart Fail; 2020 Feb; 13(2):e006541. PubMed ID: 32065760
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New York Heart Association functional class, QRS duration, and survival in heart failure with reduced ejection fraction: implications for cardiac resychronization therapy.
    Braunschweig F; Linde C; Benson L; Ståhlberg M; Dahlström U; Lund LH
    Eur J Heart Fail; 2017 Mar; 19(3):366-376. PubMed ID: 27338764
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Safety and efficacy of repeated sauna bathing in patients with chronic systolic heart failure: a preliminary report.
    Miyamoto H; Kai H; Nakaura H; Osada K; Mizuta Y; Matsumoto A; Imaizumi T
    J Card Fail; 2005 Aug; 11(6):432-6. PubMed ID: 16105634
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of repeated sauna treatment on exercise tolerance and endothelial function in patients with chronic heart failure.
    Ohori T; Nozawa T; Ihori H; Shida T; Sobajima M; Matsuki A; Yasumura S; Inoue H
    Am J Cardiol; 2012 Jan; 109(1):100-4. PubMed ID: 21944673
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Optimal noninvasive assessment of diastolic heart failure in patients with atrial fibrillation: comparison of tissue doppler echocardiography, left atrium size, and brain natriuretic peptide.
    Watanabe T; Iwai-Takano M; Oikawa M; Yamaki T; Yaoita H; Maruyama Y
    J Am Soc Echocardiogr; 2008 Jun; 21(6):689-96. PubMed ID: 17904810
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ivabradine Improves Cardiac Function and Increases Exercise Capacity in Patients with Chronic Heart Failure.
    Pei H; Miao W; Xie WZ; Wang W; Zhao D; Su GH; Zhao Z
    Int Heart J; 2019 Jul; 60(4):899-909. PubMed ID: 31308326
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Baroreflex Activation Therapy in Patients With Heart Failure With Reduced Ejection Fraction.
    Zile MR; Lindenfeld J; Weaver FA; Zannad F; Galle E; Rogers T; Abraham WT
    J Am Coll Cardiol; 2020 Jul; 76(1):1-13. PubMed ID: 32616150
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New echocardiographic predictors of clinical outcome in patients presenting with heart failure and a preserved left ventricular ejection fraction: a subanalysis of the Ka (Karolinska) Ren (Rennes) Study.
    Donal E; Lund LH; Oger E; Hage C; Persson H; Reynaud A; Ennezat PV; Bauer F; Drouet E; Linde C; Daubert C;
    Eur J Heart Fail; 2015 Jul; 17(7):680-8. PubMed ID: 26033771
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cardiac function response to stenting in atherosclerotic renal artery disease with and without heart failure: results from the Carmel study.
    Kawarada O; Kume T; Zen K; Nakamura S; Hozawa K; Akimitsu T; Asano H; Ando H; Yamamoto Y; Yamashita T; Shinozaki N; Odashiro K; Sato T; Yuba K; Sakanoue Y; Uzu T; Okada K; Fitzgerald PJ; Honda Y; Yasuda S
    ESC Heart Fail; 2019 Apr; 6(2):319-327. PubMed ID: 30614643
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Myocardial gene expression in heart failure patients treated with cardiac resynchronization therapy responders versus nonresponders.
    Vanderheyden M; Mullens W; Delrue L; Goethals M; de Bruyne B; Wijns W; Geelen P; Verstreken S; Wellens F; Bartunek J
    J Am Coll Cardiol; 2008 Jan; 51(2):129-36. PubMed ID: 18191736
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Beneficial Effect on Surrogate Markers of Heart Failure with Bisoprolol Up-Titration to Recommended Targets in Korean Patients with Heart Failure and Left Ventricular Systolic Dysfunction.
    Han SW; Choi SW; Ryu KH; Kim HJ; Kim SH; Shim WJ; Cha TJ; Choi DJ; Kim YJ; Yoo BS; Kim JH; Hwang KK; Jeon H; Shin MS
    Cardiovasc Ther; 2016 Jun; 34(3):172-9. PubMed ID: 27003232
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biventricular pacing improves quality of life and exercise tolerance in patients with heart failure and intraventricular conduction delay.
    Krahn AD; Snell L; Yee R; Finan J; Skanes AC; Klein GJ
    Can J Cardiol; 2002 Apr; 18(4):380-7. PubMed ID: 11992131
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plasma brain natriuretic peptide predicts short-term clinical outcome in heart failure patients with restrictive filling pattern.
    Feola M; Aspromonte N; Milani L; Bobbio M; Bardellotto S; Barro S; Giovinazzo P; Noventa F; Valle R
    J Card Fail; 2008 Jun; 14(5):420-5. PubMed ID: 18514935
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cardiac resynchronization therapy in patients with systolic left ventricular dysfunction and symptoms of mild heart failure secondary to ischemic or nonischemic cardiomyopathy.
    Bleeker GB; Schalij MJ; Holman ER; Steendijk P; van der Wall EE; Bax JJ
    Am J Cardiol; 2006 Jul; 98(2):230-5. PubMed ID: 16828599
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Autonomic regulation device therapy in heart failure with reduced ejection fraction: a systematic review and meta-analysis of randomized controlled trials.
    Bendary A; Bendary M; Salem M
    Heart Fail Rev; 2019 Mar; 24(2):245-254. PubMed ID: 30317416
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Baroreflex activation therapy for the treatment of heart failure with a reduced ejection fraction: safety and efficacy in patients with and without cardiac resynchronization therapy.
    Zile MR; Abraham WT; Weaver FA; Butter C; Ducharme A; Halbach M; Klug D; Lovett EG; Müller-Ehmsen J; Schafer JE; Senni M; Swarup V; Wachter R; Little WC
    Eur J Heart Fail; 2015 Oct; 17(10):1066-74. PubMed ID: 26011593
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Beneficial Effects of Ozone Therapy on Oxidative Stress, Cardiac Functions and Clinical Findings in Patients with Heart Failure Reduced Ejection Fraction.
    Buyuklu M; Kandemir FM; Set T; Bakırcı EM; Degirmenci H; Hamur H; Topal E; Kucukler S; Turkmen K
    Cardiovasc Toxicol; 2017 Oct; 17(4):426-433. PubMed ID: 28097518
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.